Regulatory Mutations and Human Genetic Disease
- 1 January 1992
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 24 (6), 427-437
- https://doi.org/10.3109/07853899209166991
Abstract
Mutations in gene promoter/regulatory regions represent an important class of lesion causing human genetic disease. Such mutations are associated with either increases or decreases in transcriptional activity mediated by the altered binding behaviour of trans-acting protein factors to specific DNA sequences in the promoter region. Although most promoter mutations are individually very infrequent, some occur at polymorphic frequencies. Both categories of lesion are likely to be important in clinical medicine and their study has already led to new insights into the mechanisms underlying the regulation of human genes.Keywords
This publication has 84 references indexed in Scilit:
- A single point mutation is the cause of the Greek form of hereditary persistence of fetal haemoglobinNature, 1992
- Transcription efficiency of human apolipoprotein A‐I promoter varies with naturally occurring A to G transitionFEBS Letters, 1992
- An A to T transversion at position −5 of the Factor IX promoter results in hemophilia BGenomics, 1992
- Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma geneNature, 1991
- Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter regionBritish Journal of Haematology, 1991
- Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia BNature, 1990
- DIRECT CARRIER TESTING IN 14 FAMILIES WITH HAEMOPHILIA BThe Lancet, 1989
- Position-independent, high-level expression of the human β-globin gene in transgenic miceCell, 1987
- Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box regionCell, 1985
- Hemophilia B LeydenNew England Journal of Medicine, 1982